Dennis M Miller

Summary

Affiliation: ZymoGenetics Inc
Country: USA

Publications

  1. ncbi Interferon lambda as a potential new therapeutic for hepatitis C
    Dennis M Miller
    ZymoGenetics, Inc, Seattle, Washington 98102, USA
    Ann N Y Acad Sci 1182:80-7. 2009

Detail Information

Publications1

  1. ncbi Interferon lambda as a potential new therapeutic for hepatitis C
    Dennis M Miller
    ZymoGenetics, Inc, Seattle, Washington 98102, USA
    Ann N Y Acad Sci 1182:80-7. 2009
    ..These preclinical and early clinical data support PEG-rIL-29 as a potential new therapeutic agent for treatment of patients with hepatitis C...